PRN: Global Rapid Influenza Diagnostic Tests Market Research Report 2017-2021

21/set/2017 18:14:58 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Rapid Influenza Diagnostic Tests Market Research Report 2017-2021

 
[21-September-2017]
 

DUBLIN, September 21, 2017 /PRNewswire/ --

The "Global Rapid Influenza Diagnostic Tests Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global rapid influenza diagnostic tests market to grow at a CAGR of 9.06% during the period 2017-2021.

Global Rapid Influenza Diagnostic Tests Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers revenue generated by the sales of RIDTs.

One trend in the market is rising technological advancements in diagnostics. The current healthcare market is shifting toward novel technology based, cost-effective devices in the diagnostic industry. There is an increasing number of manufacturers focusing on developing new-generation POC influenza tests such as LoC/microchip technology based on microelectromechanical system (MEMS). This technology mainly focusses on biological and chemical applications.

According to the report, one driver in the market is government initiatives to control and prevent ! influenza. Pandemic influenza poses a risk of human health. For instance, the recent emergence of influenza A (H1N1) virus had led to a global influenza pandemic. As a result, there is increased requirement for diagnostic tests for influenza globally. Sophisticated influenza tests are available only in specialized laboratories.

Further, the report states that one challenge in the market is product safety features of the test kits. Product safety features of any diagnostic tests are highly recommended to measure the efficacy and acceptability of a product. The product safety features ensure that the product is suitable for the consumers. Also, it ensures guarantee to the consumers that they are compliant with international standards. The regulatory organizations dealing with testing of the product features entitle the manufacturers to display specific mark accepted in particular country.

Key vendors

  • Alere
  • BD
  • Quidel

Other prominent vendors

  • bioMrieux
  • CorisBioconcept
  • Meridian Bioscience
  • Response Biomedical (acquired by OrbiMed)
  • Princeton BioMeditech Corporation
  • SA Scientific
  • Sekisui Diagnostics
  • Thermo Fisher Scientific

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By End-User

Part 08: Geographical Segmentation

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Key Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/fr846z/global_rapid

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl